The worldwide agreement to co-develop and commercialize HuMax-CD20 entered into between Genmab and GSK has received antitrust clearance.
The worldwide agreement to co-develop and commercialize HuMax-CD20 entered into between Genmab and GSK has received antitrust clearance.